Type 2 Diabetes Mellitus: Pathogenic Features and Experimental Models in Rodents

Overview

Journal Acta Naturae

Specialty Biology

Date 2022 Nov 9

PMID 36348712

Authors

I G Gvazava

m V Karimova

a V Vasiliev

E A Vorotelyak

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2DM) is the most common endocrine disorder (90%) in the world; it has numerous clinical, immunological, and genetic differences from type 1 diabetes mellitus. The pathogenesis of T2DM is complex and not fully clear. To date, animal models remain the main tool by which to study the pathophysiology and therapy of T2DM. Rodents are considered the best choice among animal models, because they are characterized by a small size, short induction period, easy diabetes induction, and economic efficiency. This review summarizes data on experimental models of T2DM that are currently used, evaluates their advantages and disadvantages vis-a-vis research, and describes in detail the factors that should be taken into account when using these models. Selection of a suitable model for tackling a particular issue is not always trivial; it affects study results and their interpretation.

Citing Articles

Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease.

Du J, Shui H, Chen R, Dong Y, Xiao C, Hu Y Curr Issues Mol Biol. 2024; 46(8):8031-8052.

PMID: 39194692 PMC: 11353077. DOI: 10.3390/cimb46080475.

Development, regeneration, and physiological expansion of functional β-cells: Cellular sources and regulators.

Chernysheva M, Ruchko E, Karimova M, Vorotelyak E, Vasiliev A Front Cell Dev Biol. 2024; 12:1424278.

PMID: 39045459 PMC: 11263198. DOI: 10.3389/fcell.2024.1424278.

Association Between the Hepatic Steatosis Index and Risk of Incident Type 2 Diabetes Mellitus in the Normoglycemic Population:A Longitudinal Prospective Study in Japan.

Si R, Xiao J, Zheng K, Yin Y, Li Y Diabetes Metab Syndr Obes. 2024; 17:2317-2326.

PMID: 38863519 PMC: 11166155. DOI: 10.2147/DMSO.S462459.

References

Lackey D, Lazaro R, Li P, Johnson A, Hernandez-Carretero A, Weber N . The role of dietary fat in obesity-induced insulin resistance. Am J Physiol Endocrinol Metab. 2016; 311(6):E989-E997. PMC: 5183884. DOI: 10.1152/ajpendo.00323.2016. View

Turer A, Khera A, Ayers C, Turer C, Grundy S, Vega G . Adipose tissue mass and location affect circulating adiponectin levels. Diabetologia. 2011; 54(10):2515-24. PMC: 4090928. DOI: 10.1007/s00125-011-2252-z. View

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505):425-32. DOI: 10.1038/372425a0. View

Bitar M, Al-Saleh E, Al-Mulla F . Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes. Life Sci. 2005; 77(20):2552-73. DOI: 10.1016/j.lfs.2005.01.033. View

Weir G, Marselli L, Marchetti P, Katsuta H, Jung M, Bonner-Weir S . Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab. 2009; 11 Suppl 4:82-90. DOI: 10.1111/j.1463-1326.2009.01113.x. View

Torre-Villalvazo I, Cervantes-Perez L, Noriega L, Jimenez J, Uribe N, Chavez-Canales M . Inactivation of SPAK kinase reduces body weight gain in mice fed a high-fat diet by improving energy expenditure and insulin sensitivity. Am J Physiol Endocrinol Metab. 2017; 314(1):E53-E65. DOI: 10.1152/ajpendo.00108.2017. View

Ranaei Pirmardan E, Barakat A, Zhang Y, Naseri M, Hafezi-Moghadam A . Diabetic cataract in the Nile grass rat: A longitudinal phenotypic study of pathology formation. FASEB J. 2021; 35(6):e21593. DOI: 10.1096/fj.202100353R. View

Heydemann A . An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus. J Diabetes Res. 2016; 2016:2902351. PMC: 4983380. DOI: 10.1155/2016/2902351. View

Yaribeygi H, Farrokhi F, Butler A, Sahebkar A . Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. 2018; 234(6):8152-8161. DOI: 10.1002/jcp.27603. View

10.

Sinasac D, Riordan J, Spiezio S, Yandell B, Croniger C, Nadeau J . Genetic control of obesity, glucose homeostasis, dyslipidemia and fatty liver in a mouse model of diet-induced metabolic syndrome. Int J Obes (Lond). 2015; 40(2):346-55. DOI: 10.1038/ijo.2015.184. View

11.

Winzell M, Ahren B . The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004; 53 Suppl 3:S215-9. DOI: 10.2337/diabetes.53.suppl_3.s215. View

12.

Asiri M, Engelsman S, Eijkelkamp N, Hoppener J . Amyloid Proteins and Peripheral Neuropathy. Cells. 2020; 9(6). PMC: 7349787. DOI: 10.3390/cells9061553. View

13.

Duvnjak L, Duvnjak M . The metabolic syndrome - an ongoing story. J Physiol Pharmacol. 2010; 60 Suppl 7:19-24. View

14.

Almind K, Kahn C . Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes. 2004; 53(12):3274-85. DOI: 10.2337/diabetes.53.12.3274. View

15.

Aguayo-Mazzucato C, van Haaren M, Mruk M, Lee Jr T, Crawford C, Hollister-Lock J . β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance. Cell Metab. 2017; 25(4):898-910.e5. PMC: 5471618. DOI: 10.1016/j.cmet.2017.03.015. View

16.

Latouche C, Natoli A, Reddy-Luthmoodoo M, Heywood S, Armitage J, Kingwell B . MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes. PLoS One. 2016; 11(5):e0155108. PMC: 4862646. DOI: 10.1371/journal.pone.0155108. View

17.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

18.

Fang R, Kryger Z, Buck 2nd D, De la Garza M, Galiano R, Mustoe T . Limitations of the db/db mouse in translational wound healing research: Is the NONcNZO10 polygenic mouse model superior?. Wound Repair Regen. 2010; 18(6):605-13. DOI: 10.1111/j.1524-475X.2010.00634.x. View

19.

Sarparanta J, Garcia-Macia M, Singh R . Autophagy and Mitochondria in Obesity and Type 2 Diabetes. Curr Diabetes Rev. 2016; 13(4):352-369. DOI: 10.2174/1573399812666160217122530. View

20.

Gault V, Kerr B, Harriott P, Flatt P . Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity. Clin Sci (Lond). 2011; 121(3):107-17. DOI: 10.1042/CS20110006. View